ABILIFY MAINTENA (aripiprazole) is indicated for: Treatment of schizophrenia in adults [see Pharmacology: Pharmacodynamics: Clinical Studies: Schizophrenia under Actions]; Maintenance monotherapy treatment of bipolar I disorder in adults [see Pharmacology: Pharmacodynamics: Clinical Studies: Bipolar I Disorder-Maintenance Monotherapy under Actions].